Literature DB >> 11018075

Complete antithrombin deficiency in mice results in embryonic lethality.

K Ishiguro1, T Kojima, K Kadomatsu, Y Nakayama, A Takagi, M Suzuki, N Takeda, M Ito, K Yamamoto, T Matsushita, K Kusugami, T Muramatsu, H Saito.   

Abstract

Antithrombin is a plasma protease inhibitor that inhibits thrombin and contributes to the maintenance of blood fluidity. Using targeted gene disruption, we investigated the role of antithrombin in embryogenesis. Mating mice heterozygous for antithrombin gene (ATIII) disruption, ATIII(+/-), yielded the expected Mendelian distribution of genotypes until 14.5 gestational days (gd). However, approximately 70% of the ATIII(-/-) embryos at 15.5 gd and 100% at 16.5 gd had died and showed extensive subcutaneous hemorrhage. Histological examination of those embryos revealed extensive fibrin(ogen) deposition in the myocardium and liver, but not in the brain or lung. Furthermore, no apparent fibrin(ogen) deposition was detected in the extensive hemorrhagic region, suggesting that fibrinogen might be decreased due to consumptive coagulopathy and/or liver dysfunction. These findings suggest that antithrombin is essential for embryonic survival and that it plays an important role in regulation of blood coagulation in the myocardium and liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018075      PMCID: PMC517819          DOI: 10.1172/JCI10489

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions.

Authors:  K Ishiguro; K Kadomatsu; T Kojima; H Muramatsu; S Tsuzuki; E Nakamura; K Kusugami; H Saito; T Muramatsu
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Anticoagulantly active heparin-like molecules from vascular tissue.

Authors:  J A Marcum; R D Rosenberg
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

5.  Microvascular heparin-like species with anticoagulant activity.

Authors:  J A Marcum; L Fritze; S J Galli; G Karp; R D Rosenberg
Journal:  Am J Physiol       Date:  1983-11

6.  Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.

Authors:  T Kojima; C W Leone; G A Marchildon; J A Marcum; R D Rosenberg
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

7.  Homozygous variant of antithrombin III: AT III Fontainebleau.

Authors:  C Boyer; M Wolf; J Vedrenne; D Meyer; M J Larrieu
Journal:  Thromb Haemost       Date:  1986-08-20       Impact factor: 5.249

8.  Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.

Authors:  K Okajima; H Ueyama; Y Hashimoto; Y Sasaki; K Matsumoto; H Okabe; M Inoue; S Araki; K Takatsuki
Journal:  Thromb Haemost       Date:  1989-02-28       Impact factor: 5.249

Review 9.  Antithrombin: structure, genomic organization, function and inherited deficiency.

Authors:  D A Lane; R Caso
Journal:  Baillieres Clin Haematol       Date:  1989-10

10.  Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.

Authors:  I Maruyama; C E Bell; P W Majerus
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

View more
  51 in total

Review 1.  Heparan sulfate: antithrombotic or not?

Authors:  Jeffrey I Weitz
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

Authors:  Sassan HajMohammadi; Keiichi Enjyoji; Marc Princivalle; Patricia Christi; Miroslav Lech; David Beeler; Helen Rayburn; John J Schwartz; Samad Barzegar; Ariane I de Agostini; Mark J Post; Robert D Rosenberg; Nicholas W Shworak
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 3.  Plasmodium falciparum picks (on) EPCR.

Authors:  William C Aird; Laurent O Mosnier; Rick M Fairhurst
Journal:  Blood       Date:  2013-11-18       Impact factor: 22.113

4.  Heparin cofactor II inhibits arterial thrombosis after endothelial injury.

Authors:  Li He; Cristina P Vicente; Randal J Westrick; Daniel T Eitzman; Douglas M Tollefsen
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 5.  Advances and innovations in haemophilia treatment.

Authors:  Rob Peters; Tim Harris
Journal:  Nat Rev Drug Discov       Date:  2018-06-08       Impact factor: 84.694

6.  Expression and functional characterization of two natural heparin-binding site variants of antithrombin.

Authors:  P Dinarvand; L Yang; B O Villoutreix; A R Rezaie
Journal:  J Thromb Haemost       Date:  2018-01-08       Impact factor: 5.824

7.  Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice.

Authors:  James P Luyendyk; Glenn H Cantor; Daniel Kirchhofer; Nigel Mackman; Bryan L Copple; Ruipeng Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

Review 8.  Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.

Authors:  Nicholas W Shworak; Sassan HajMohammadi; Ariane I de Agostini; Robert D Rosenberg
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice.

Authors:  Cristina P Vicente; Li He; Douglas M Tollefsen
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

10.  Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.

Authors:  T J Girard; N M Lasky; K Grunz; G J Broze
Journal:  J Thromb Haemost       Date:  2018-12-16       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.